A 62-year-old woman with advanced pancreatic cancer is admitted to the ICU with refractory nausea and vomiting despite optimized pharmacologic therapy. Her family reports that she often stops taking her prescribed antiemetics because she does not understand their importance or how to properly use them. She has stable insurance coverage and no reported financial difficulties in affording medications. However, she lives alone and has limited social support. In this critically ill patient with advanced pancreatic cancer and refractory nausea, which social determinant of health should be prioritized to enhance long-term antiemetic adherence and reduce future symptom exacerbations?

A 58-year-old man is admitted to the ICU with septic shock from pneumonia. He is on mechanical ventilation and a continuous fentanyl infusion for analgesia. His history includes chronic liver disease with thrombocytopenia (platelets 60 × 10^3/µL), and he receives a proton-pump inhibitor for stress-ulcer prophylaxis. Enteral feeding was started 48 hours ago. Over the past 24 hours, he has developed progressive abdominal distension, nausea, and intermittent vomiting. Which of the following best explains the primary drivers of his current gastrointestinal symptoms?

A 58-year-old man with decompensated alcoholic cirrhosis is admitted to the medical ward with 5 days of intractable nausea and vomiting. He weighs 75 kg (BMI 24 kg/m2) and has tense ascites managed with spironolactone 100 mg daily and furosemide 40 mg daily, and hepatic encephalopathy controlled on lactulose 30 mL every 8 hours. Over the past 3 days his serum creatinine rose from a baseline of 1.0 to 2.3 mg/dL, consistent with hepatorenal syndrome–acute kidney injury (HRS-AKI). On exam: BP 92/56 mmHg, HR 98/min, RR 18/min, T 37.0 °C. He is alert and oriented; mucous membranes are dry; he has 3+ pitting edema and tense shifting dullness. Initial labs: Na 125 mEq/L, BUN 48 mg/dL, AST 72 U/L, ALT 65 U/L, total bilirubin 4.2 mg/dL, and serum ammonia 35 µmol/L (normal <50 µmol/L). He has received ondansetron 4 mg IV every 6 hours and metoclopramide 10 mg IV every 8 hours without relief. Which pathophysiological mechanism is most likely the primary driver of his severe, refractory nausea and vomiting?

A 68-year-old male (weight 70 kg) with stage 4 chronic kidney disease (baseline creatinine 1.5 mg/dL) is admitted to the ICU for septic shock. He remains hypotensive (85/50 mmHg) on norepinephrine, tachycardic (110 bpm), and febrile (38.3 °C). Over the past 72 hours he has had severe nausea and intractable vomiting despite ondansetron 4 mg IV every 6 hours. His current creatinine is 3.2 mg/dL and BUN is 65 mg/dL. He is receiving a continuous fentanyl infusion for sedation. Which pathophysiological mechanism is most likely driving his persistent nausea and vomiting, guiding the selection of the next antiemetic agent?

A 58-year-old woman with metastatic breast cancer is admitted to the ICU with septic shock. She has experienced severe, persistent nausea and vomiting for the past 24 hours despite standard antiemetic therapy. As the critical care pharmacist, you need an objective, severity-based classification system for chemotherapy-related adverse events to rapidly stratify symptom severity and guide the urgency of intervention. Which tool is most appropriate?

A 62-year-old man with known cirrhosis and ascites is admitted to the ICU for acute hypoxic respiratory failure and septic shock. He is receiving a continuous fentanyl infusion for analgesia. On hospital day 3, he develops new nausea, vomiting, diffuse abdominal pain, fever, abdominal distension, tenderness, and diminished bowel sounds. Laboratory studies reveal leukocytosis, an elevated lactate, and worsening renal function. Given this presentation, which diagnosis should be excluded first, requiring immediate diagnostic paracentesis to guide management?

A 62-year-old man with advanced pancreatic head adenocarcinoma is admitted to the ICU for severe nausea, persistent nonbloody vomiting, and worsening epigastric pain radiating to the back. Laboratory studies show serum amylase 1,200 U/L, lipase 2,500 U/L, mild elevations in AST, ALT, total bilirubin, and alkaline phosphatase, as well as hypokalemia and metabolic alkalosis. An abdominal X-ray reveals dilated small-bowel loops with air-fluid levels concerning for obstruction. However, contrast-enhanced CT demonstrates diffuse pancreatic enlargement, peripancreatic fluid collections, and no evidence of luminal narrowing or extrinsic mass effect on the bowel. Which of the following is the MOST likely primary etiology of his acute gastrointestinal symptoms?

A 62-year-old man in the intensive care unit for septic shock is receiving high-dose intravenous opioids for analgesia. He is NPO with enteral nutrition via a nasogastric tube. Over the past 24 hours, his gastric residual volumes have remained elevated (>300 mL), and he continues to have severe nausea and vomiting. Which of the following is the MOST appropriate initial pharmacologic agent to prioritize for his nausea and vomiting?

An 82-year-old woman with end-stage metastatic ovarian cancer complicated by malignant bowel obstruction is receiving comfort-measures-only care in the ICU. Over the past 48 hours, she has had persistent, intractable nausea and vomiting and cannot tolerate any oral intake. A nasogastric tube is in place, but delayed gastric emptying limits enteral absorption. She received two 4 mg IV ondansetron boluses and had a scopolamine patch applied 48 hours ago with minimal relief. Vital signs are stable, and her primary goal is comfort. Which pharmacotherapy plan for ongoing nausea and vomiting control is most appropriate?

A 65-year-old man with a history of heart failure and atrial fibrillation (baseline QTc 460 ms) is intubated in the ICU for severe community-acquired pneumonia. He has persistent nausea and vomiting despite ondansetron 4 mg IV every 6 hours and has been started on haloperidol 1 mg IV every 8 hours. Electrolytes are within normal limits. Considering the risks of QT prolongation and extrapyramidal symptoms, which of the following represents the most appropriate comprehensive monitoring plan for his antiemetic therapy?